Events

Deprescribing Antidepressants - Webinar

The overuse of psychiatric medications has become a growing concern for key healthcare and regulatory bodies. Deprescribing is a positive, patient-centred intervention carried out under medical supervision. It involves reassessing the role of all medicines to determine if any should be stopped - whether they no longer provide clear benefits, may cause harm, are being used for a condition that is no longer relevant or no longer align with the patient's current goals of care. 

We invite you to attend an important webinar featuring Dr Mark Horowitz and Professor Katharine Wallis. This session will offer valuable insights and practical strategies for deprescribing. Dr Horowitz will provide valuable insights into how to use the evidence-based hyperbolic tapering approach to safely reduce or stop the use of psychotropic medications, whilst managing withdrawal symptoms and ensuring patient safety. Professor Wallis will discuss details of her RELEASE trial - an intervention designed to support people to safely stop antidepressants. 

AUDIENCE: GPs, Pharmacists, health professionals and service providers involved in supporting individuals on psychiatric medications.  

SPEAKERS: 

• Dr Mark Horowitz, MBBS PhD
• Professor Katharine Wallis, MBChB, PhD, MBHL, Dip Obst, FRNZCGP, FACRRM, GAICD

TOPICS:

• Deprescribing strategies
• Managing withdrawal symptoms and ensuring patient safety
• RELEASE Trial

TIME:

Start: 6.30pm

Finish: 8.00pm

Register Here